mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |